Recombinant Human TNKS1 Protein，His

TNKS1, or Tankyrase 1, is a member of the PARP (Poly(ADP-ribose) polymerase) family of proteins, primarily involved in the regulation of cellular processes such as cell proliferation, apoptosis, and telomere maintenance. It plays a crucial role in the Wnt signaling pathway by modulating β-catenin levels, thereby influencing oncogenic signaling pathways that are often dysregulated in various cancers. Given the significant impact of TNKS1 on tumorigenesis, it has emerged as a potential therapeutic target, prompting extensive research into the development of TNKS1 inhibitors. The study of recombinant TNKS1 protein allows researchers to explore its biochemical properties, interaction with various substrates, and regulatory mechanisms in detail. Furthermore, the production of recombinant TNKS1 facilitates the high-throughput screening of small molecule inhibitors, which could lead to novel cancer treatments. Understanding the structure-function relationship of TNKS1 through structural biology techniques can reveal insights into its active sites and binding mechanisms, paving the way for the design of more effective drugs. Additionally, investigating TNKS1's role beyond cancer, such as in aging and other diseases, highlights its versatility and potential as a multi-faceted therapeutic target. As a result, TNKS1 recombinant protein research not only contributes to the foundational knowledge of cell biology and cancer mechanisms but also opens avenues for innovative pharmacological interventions.